Bernice Moye, | |
5 E Harbor Ct, Sacramento, CA 95831-5612 | |
(916) 393-9587 | |
Not Available |
Full Name | Bernice Moye |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | 5 E Harbor Ct, Sacramento, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1114339157 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | RPH35378 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Bernice Moye, 5 E Harbor Ct, Sacramento, CA 95831-5612 Ph: (916) 393-9587 | Bernice Moye, 5 E Harbor Ct, Sacramento, CA 95831-5612 Ph: (916) 393-9587 |
News Archive
Sanofi announced today that the LixiLan-O Phase III clinical trial met its primary objective in patients with type 2 diabetes treated with metformin. The fixed-ratio combination of insulin glargine 100 units/mL and lixisenatide, a GLP-1 RA, demonstrated statistically superior reduction in HbA1c (average blood glucose over the previous three months) compared with lixisenatide and compared with insulin glargine 100 units/mL.
Nevro Corp., a medical device company focused on achieving improved pain relief for patients suffering from debilitating chronic pain, today announced that the U.S. Food and Drug Administration (FDA) has granted approval for initiation of its SENZA-RCT study, a U.S. prospective, randomized, controlled pivotal clinical trial evaluating the safety and efficacy of Nevro's high-frequency spinal cord stimulation system for the treatment of chronic pain.
Novel molecules called selective androgen receptor degraders (SARDs) may offer the next generation of treatment options for advanced prostate cancer, a new industry-sponsored study reports. The results of this research will be presented Saturday, April 1, at ENDO 2017, the 99th annual meeting of the Endocrine Society, in Orlando, Fla.
In the UK the country's watchdog for cost-effectiveness in medical treatments, the National Institute for Health and Clinical Excellence (NICE), has asked drug makers for more evidence about the benefits of their Alzheimer's medicines.
An important finding, which could eventually lead to a new therapeutic approach for treating autoimmune and inflammatory diseases such as rheumatoid arthritis, colitis, psoriasis and others, was announced by researchers at the La Jolla Institute for Allergy & Immunology (LIAI).
› Verified 9 days ago
Dr. Gina Maria Warren, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4600 Broadway, Coumadin Clinic, Sacramento, CA 95820 Phone: 916-335-8818 | |
Dr. John Sung, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2825 Capitol Ave, Sacramento, CA 95816 Phone: 916-887-0350 | |
Mr. Gerald Lee Freitas I, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8364 Rovana Cir, Sacramento, CA 95828 Phone: 916-379-1657 Fax: 916-379-1691 | |
Michele Ang, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3521 Del Paso Rd, Sacramento, CA 95835 Phone: 951-310-0758 | |
Colette Newman, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4650 Natomas Blvd, Sacramento, CA 95835 Phone: 916-419-6644 Fax: 916-419-4764 | |
Dr. Anh Minh Phan, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6051 Florin Rd, Sacramento, CA 95823 Phone: 916-427-9731 | |
Dr. Joyce He, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8241 E Stockton Blvd, Pharmacy Administration, Sacramento, CA 95828 Phone: 916-525-6900 |